Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Howze Yalonda | See Remarks | 19 | $0 | $5.5K | 2023-03-30 |
| Sathyanarayanan Sriram | Chief Scientific Officer | 24 | $0 | $63.3K | 2023-03-29 |
| Barna Nicole | See Remarks | 19 | $50.0K | $4.7K | 2023-03-29 |
| Konstantinov Konstantin | See Remarks | 22 | $0 | $192.5K | 2023-03-28 |
| Bain Linda | Chief Financial Officer | 17 | $0 | $10.1K | 2023-03-28 |
| WILLIAMS DOUGLAS E | See Remarks | 18 | $0 | $30.7K | 2023-03-28 |
| Haddock Jason | Director | 9 | $0 | $0 | 2023-02-16 |
| Bernstein Karen | Director | 7 | $0 | $0 | 2023-02-16 |
| GILLIS STEVEN | Director | 14 | $3.52M | $0 | 2023-02-16 |
| MELAS KYRIAZI THEO | Director | 8 | $99.0K | $0 | 2023-02-16 |
| COONEY CHARLES L | Director | 7 | $0 | $0 | 2023-02-16 |
| Mauro David J | Chief Medical Officer | 4 | $0 | $0 | 2023-01-24 |
| Flagship V VentureLabs Rx Fund, L.P. | 10% Owner | 4 | $0 | $0 | 2022-09-15 |
| ARCH Venture Fund VIII Overage, L.P. | 10% Owner | 2 | $7.50M | $0 | 2022-09-13 |
| Eggimann Anne-Virginie | Director | 3 | $0 | $0 | 2022-06-17 |
| Pandite Arundathy N. | Director | 3 | $0 | $0 | 2022-06-17 |
| Brudnick Richard | See Remarks | 5 | $0 | $0 | 2022-02-16 |
| Sorensen Benny | See Remarks | 5 | $0 | $219.0K | 2021-06-08 |
| Wheler Jennifer J. | Chief Medical Officer | 1 | $0 | $0 | 2021-05-10 |
| Morrison Briggs | Director | 2 | $100.0K | $0 | 2021-02-17 |
| Verma Ajay | See Remarks | 1 | $0 | $0 | 2021-01-22 |
| Flagship Ventures Fund V General Partner LLC | 10% Owner | 13 | $2.48M | $0 | 2020-10-16 |
| Alaska Permanent Fund Corp | 10% Owner | 11 | $3.52M | $0 | 2020-10-16 |
| CRANDELL KEITH | 10% Owner | 11 | $3.52M | $0 | 2020-10-16 |
| LANDER ERIC S | Director | 1 | $0 | $0 | 2020-10-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Howze Yalonda | See Remarks | S Sale | 2023-03-30 | 2023-03-30 | 1,628 | $0.20 | $326 | 7,458 | SEC↗ |
| Barna Nicole | See Remarks | S Sale | 2023-03-29 | 2023-03-30 | 1,932 | $0.17 | $328 | 4,849 | SEC↗ |
| Barna Nicole | See Remarks | S Sale | 2023-03-29 | 2023-03-30 | 5,373 | $0.17 | $913 | 6,781 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | S Sale | 2023-03-29 | 2023-03-30 | 11,762 | $0.17 | $2.0K | 0 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | S Sale | 2023-03-28 | 2023-03-30 | 41,667 | $0.18 | $7.5K | 7,655 | SEC↗ |
| Bain Linda | Chief Financial Officer | S Sale | 2023-03-28 | 2023-03-30 | 13,412 | $0.17 | $2.3K | 0 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | S Sale | 2023-03-28 | 2023-03-30 | 1,932 | $0.20 | $386 | 0 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | S Sale | 2023-03-28 | 2023-03-30 | 7,432 | $0.20 | $1.5K | 1,932 | SEC↗ |
| Howze Yalonda | See Remarks | S Sale | 2023-02-17 | 2023-02-21 | 1,603 | $0.59 | $946 | 9,086 | SEC↗ |
| Barna Nicole | See Remarks | S Sale | 2023-02-17 | 2023-02-21 | 1,274 | $0.59 | $752 | 12,154 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | S Sale | 2023-02-17 | 2023-02-21 | 2,407 | $0.59 | $1.4K | 11,762 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | S Sale | 2023-02-17 | 2023-02-21 | 7,681 | $0.59 | $4.5K | 49,322 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | S Sale | 2023-02-17 | 2023-02-21 | 1,391 | $0.59 | $821 | 7,432 | SEC↗ |
| Bain Linda | Chief Financial Officer | S Sale | 2023-02-17 | 2023-02-21 | 2,570 | $0.59 | $1.5K | 13,412 | SEC↗ |
| Howze Yalonda | See Remarks | M Exercise deriv | 2023-02-16 | 2023-02-21 | 4,856 | — | $0 | 9,712 | SEC↗ |
| MELAS KYRIAZI THEO | Director | M Exercise deriv | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 0 | SEC↗ |
| Barna Nicole | See Remarks | M Exercise deriv | 2023-02-16 | 2023-02-21 | 3,150 | — | $0 | 6,300 | SEC↗ |
| COONEY CHARLES L | Director | M Exercise deriv | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise deriv | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 0 | SEC↗ |
| Haddock Jason | Director | M Exercise deriv | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 0 | SEC↗ |
| Bernstein Karen | Director | M Exercise deriv | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 0 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise deriv | 2023-02-16 | 2023-02-21 | 7,350 | — | $0 | 14,700 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | M Exercise deriv | 2023-02-16 | 2023-02-21 | 22,969 | — | $0 | 45,937 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | M Exercise deriv | 2023-02-16 | 2023-02-21 | 4,200 | — | $0 | 8,400 | SEC↗ |
| Bain Linda | Chief Financial Officer | M Exercise deriv | 2023-02-16 | 2023-02-21 | 7,613 | — | $0 | 15,224 | SEC↗ |
| Howze Yalonda | See Remarks | M Exercise | 2023-02-16 | 2023-02-21 | 4,856 | — | $0 | 10,689 | SEC↗ |
| MELAS KYRIAZI THEO | Director | M Exercise | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 15,350 | SEC↗ |
| Barna Nicole | See Remarks | M Exercise | 2023-02-16 | 2023-02-21 | 3,150 | — | $0 | 13,428 | SEC↗ |
| COONEY CHARLES L | Director | M Exercise | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 8,750 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Haddock Jason | Director | M Exercise | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Bernstein Karen | Director | M Exercise | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise | 2023-02-16 | 2023-02-21 | 7,350 | — | $0 | 14,169 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | M Exercise | 2023-02-16 | 2023-02-21 | 22,969 | — | $0 | 57,003 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | M Exercise | 2023-02-16 | 2023-02-21 | 4,200 | — | $0 | 8,823 | SEC↗ |
| Bain Linda | Chief Financial Officer | M Exercise | 2023-02-16 | 2023-02-21 | 7,613 | — | $0 | 15,982 | SEC↗ |
| Barna Nicole | See Remarks | A Award deriv | 2023-01-24 | 2023-01-26 | 105,000 | — | $0 | 105,000 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | A Award deriv | 2023-01-24 | 2023-01-26 | 465,000 | — | $0 | 465,000 | SEC↗ |
| Howze Yalonda | See Remarks | A Award deriv | 2023-01-24 | 2023-01-26 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Bain Linda | Chief Financial Officer | A Award deriv | 2023-01-24 | 2023-01-26 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | A Award deriv | 2023-01-24 | 2023-01-26 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | A Award deriv | 2023-01-24 | 2023-01-26 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Mauro David J | Chief Medical Officer | A Award deriv | 2023-01-24 | 2023-01-26 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Barna Nicole | See Remarks | S Sale | 2023-01-20 | 2023-01-23 | 836 | $0.58 | $485 | 8,112 | SEC↗ |
| Howze Yalonda | See Remarks | S Sale | 2023-01-20 | 2023-01-23 | 1,512 | $0.58 | $877 | 2,488 | SEC↗ |
| WILLIAMS DOUGLAS E | See Remarks | S Sale | 2023-01-20 | 2023-01-23 | 5,075 | $0.58 | $2.9K | 18,177 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | S Sale | 2023-01-20 | 2023-01-23 | 1,082 | $0.58 | $628 | 1,752 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | S Sale | 2023-01-20 | 2023-01-23 | 1,069 | $0.58 | $620 | 1,731 | SEC↗ |
| Bain Linda | Chief Financial Officer | S Sale | 2023-01-20 | 2023-01-23 | 1,880 | $0.58 | $1.1K | 3,120 | SEC↗ |
| Barna Nicole | See Remarks | M Exercise deriv | 2023-01-19 | 2023-01-23 | 2,167 | — | $0 | 4,333 | SEC↗ |
| Howze Yalonda | See Remarks | M Exercise deriv | 2023-01-19 | 2023-01-23 | 4,000 | — | $0 | 8,000 | SEC↗ |
| WILLIAMS DOUGLAS E | See Remarks | M Exercise deriv | 2023-01-19 | 2023-01-23 | 13,667 | — | $0 | 27,333 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise deriv | 2023-01-19 | 2023-01-23 | 2,834 | — | $0 | 5,666 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | M Exercise deriv | 2023-01-19 | 2023-01-23 | 2,800 | — | $0 | 5,600 | SEC↗ |
| Bain Linda | Chief Financial Officer | M Exercise deriv | 2023-01-19 | 2023-01-23 | 5,000 | — | $0 | 10,000 | SEC↗ |
| Barna Nicole | See Remarks | M Exercise | 2023-01-19 | 2023-01-23 | 2,167 | — | $0 | 8,948 | SEC↗ |
| Howze Yalonda | See Remarks | M Exercise | 2023-01-19 | 2023-01-23 | 4,000 | — | $0 | 4,000 | SEC↗ |
| WILLIAMS DOUGLAS E | See Remarks | M Exercise | 2023-01-19 | 2023-01-23 | 13,667 | — | $0 | 23,252 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise | 2023-01-19 | 2023-01-23 | 2,834 | — | $0 | 2,834 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | M Exercise | 2023-01-19 | 2023-01-23 | 2,800 | — | $0 | 2,800 | SEC↗ |
| Bain Linda | Chief Financial Officer | M Exercise | 2023-01-19 | 2023-01-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Howze Yalonda | See Remarks | A Award deriv | 2022-09-16 | 2022-09-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| See Remarks | A Award deriv | 2022-09-16 | 2022-09-20 | 80,000 | — | $0 | 80,000 | SEC↗ | |
| Konstantinov Konstantin | Chief Technology Officer | A Award deriv | 2022-09-16 | 2022-09-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Mauro David J | Chief Medical Officer | A Award deriv | 2022-09-16 | 2022-09-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Bain Linda | Chief Financial Officer | A Award deriv | 2022-09-16 | 2022-09-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | A Award deriv | 2022-09-16 | 2022-09-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Flagship V VentureLabs Rx Fund | 10% Owner | P Buy deriv | 2022-09-15 | 2022-09-16 | 722,590 | — | $0 | 722,590 | SEC↗ |
| Flagship V VentureLabs Rx Fund | 10% Owner | P Buy deriv | 2022-09-15 | 2022-09-16 | 210,743 | — | $0 | 210,743 | SEC↗ |
| Flagship V VentureLabs Rx Fund | 10% Owner | P Buy | 2022-09-15 | 2022-09-16 | 210,743 | — | $0 | 1,188,920 | SEC↗ |
| Flagship V VentureLabs Rx Fund | 10% Owner | P Buy | 2022-09-15 | 2022-09-16 | 722,590 | — | $0 | 1,865,767 | SEC↗ |
| ARCH Venture Fund VIII Overage | 10% Owner | P Buy deriv | 2022-09-13 | 2022-09-15 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| GILLIS STEVEN | Director | P Buy deriv | 2022-09-13 | 2022-09-15 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| ARCH Venture Fund VIII Overage | 10% Owner | P Buy | 2022-09-13 | 2022-09-15 | 5,000,000 | $1.50 | $7.50M | 8,854,098 | SEC↗ |
| GILLIS STEVEN | Director | P Buy | 2022-09-13 | 2022-09-15 | 5,000,000 | — | $0 | 7,503,903 | SEC↗ |
| Howze Yalonda | See Remarks | S Sale | 2022-08-17 | 2023-02-21 | 1,512 | $2.21 | $3.3K | 5,833 | SEC↗ |
| Barna Nicole | See Remarks | S Sale | 2022-08-17 | 2023-02-21 | 984 | $2.21 | $2.2K | 10,278 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | S Sale | 2022-08-17 | 2023-02-21 | 2,283 | $2.21 | $5.0K | 6,819 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | S Sale | 2022-08-17 | 2023-02-21 | 7,112 | $2.21 | $15.7K | 34,034 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | S Sale | 2022-08-17 | 2023-02-21 | 1,308 | $2.21 | $2.9K | 4,623 | SEC↗ |
| Bain Linda | Chief Financial Officer | S Sale | 2022-08-17 | 2023-02-21 | 2,364 | $2.21 | $5.2K | 8,369 | SEC↗ |
| Howze Yalonda | See Remarks | M Exercise deriv | 2022-08-16 | 2023-02-21 | 4,857 | — | $0 | 14,568 | SEC↗ |
| Barna Nicole | See Remarks | M Exercise deriv | 2022-08-16 | 2023-02-21 | 3,150 | — | $0 | 9,450 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise deriv | 2022-08-16 | 2023-02-21 | 7,350 | — | $0 | 22,050 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | M Exercise deriv | 2022-08-16 | 2023-02-21 | 22,969 | — | $0 | 68,906 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | M Exercise deriv | 2022-08-16 | 2023-02-21 | 4,200 | — | $0 | 12,600 | SEC↗ |
| Bain Linda | Chief Financial Officer | M Exercise deriv | 2022-08-16 | 2023-02-21 | 7,613 | — | $0 | 22,837 | SEC↗ |
| Howze Yalonda | See Remarks | M Exercise | 2022-08-16 | 2023-02-21 | 4,857 | — | $0 | 7,345 | SEC↗ |
| Barna Nicole | See Remarks | M Exercise | 2022-08-16 | 2023-02-21 | 3,150 | — | $0 | 11,262 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise | 2022-08-16 | 2023-02-21 | 7,350 | — | $0 | 9,102 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | M Exercise | 2022-08-16 | 2023-02-21 | 22,969 | — | $0 | 41,146 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | M Exercise | 2022-08-16 | 2023-02-21 | 4,200 | — | $0 | 5,931 | SEC↗ |
| Bain Linda | Chief Financial Officer | M Exercise | 2022-08-16 | 2023-02-21 | 7,613 | — | $0 | 10,733 | SEC↗ |
| Pandite Arundathy N. | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Pandite Arundathy N. | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 1,500 | — | $0 | 1,500 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 1,500 | — | $0 | 1,500 | SEC↗ |
| COONEY CHARLES L | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| COONEY CHARLES L | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 1,500 | — | $0 | 1,500 | SEC↗ |
| MELAS KYRIAZI THEO | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| MELAS KYRIAZI THEO | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Eggimann Anne-Virginie | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Eggimann Anne-Virginie | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Bernstein Karen | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Bernstein Karen | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Haddock Jason | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Haddock Jason | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Mauro David J | Chief Medical Officer | A Award deriv | 2022-05-02 | 2022-05-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Mauro David J | Chief Medical Officer | A Award deriv | 2022-05-02 | 2022-05-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | A Award deriv | 2022-02-16 | 2022-02-18 | 16,800 | — | $0 | 16,800 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | A Award deriv | 2022-02-16 | 2022-02-18 | 11,200 | — | $0 | 11,200 | SEC↗ |
| Haddock Jason | Director | A Award deriv | 2022-02-16 | 2022-02-18 | 8,750 | — | $0 | 8,750 | SEC↗ |
| MELAS KYRIAZI THEO | Director | A Award deriv | 2022-02-16 | 2022-02-18 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Barna Nicole | See Remarks | A Award deriv | 2022-02-16 | 2022-02-18 | 8,400 | — | $0 | 8,400 | SEC↗ |
| Barna Nicole | See Remarks | A Award deriv | 2022-02-16 | 2022-02-18 | 12,600 | — | $0 | 12,600 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | A Award deriv | 2022-02-16 | 2022-02-18 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | A Award deriv | 2022-02-16 | 2022-02-18 | 29,400 | — | $0 | 29,400 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | A Award deriv | 2022-02-16 | 2022-02-18 | 61,250 | — | $0 | 61,250 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | A Award deriv | 2022-02-16 | 2022-02-18 | 91,875 | — | $0 | 91,875 | SEC↗ |
| COONEY CHARLES L | Director | A Award deriv | 2022-02-16 | 2022-02-18 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Howze Yalonda | See Remarks | A Award deriv | 2022-02-16 | 2022-02-18 | 12,950 | — | $0 | 12,950 | SEC↗ |
| Howze Yalonda | See Remarks | A Award deriv | 2022-02-16 | 2022-02-18 | 19,425 | — | $0 | 19,425 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2022-02-16 | 2022-02-18 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Bain Linda | Chief Financial Officer | A Award deriv | 2022-02-16 | 2022-02-18 | 30,450 | — | $0 | 30,450 | SEC↗ |
| Bain Linda | Chief Financial Officer | A Award deriv | 2022-02-16 | 2022-02-18 | 20,300 | — | $0 | 20,300 | SEC↗ |
| Brudnick Richard | See Remarks | A Award deriv | 2022-02-16 | 2022-02-18 | 10,850 | — | $0 | 10,850 | SEC↗ |
| Brudnick Richard | See Remarks | A Award deriv | 2022-02-16 | 2022-02-18 | 16,275 | — | $0 | 16,275 | SEC↗ |
| Bernstein Karen | Director | A Award deriv | 2022-02-16 | 2022-02-18 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Barna Nicole | See Remarks | P Buy | 2022-01-20 | 2022-02-07 | 6,781 | $7.37 | $50.0K | 6,781 | SEC↗ |
| Bain Linda | Chief Financial Officer | A Award deriv | 2022-01-19 | 2022-01-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Bain Linda | Chief Financial Officer | A Award deriv | 2022-01-19 | 2022-01-21 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | A Award deriv | 2022-01-19 | 2022-01-21 | 8,400 | — | $0 | 8,400 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | A Award deriv | 2022-01-19 | 2022-01-21 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Barna Nicole | See Remarks | A Award deriv | 2022-01-19 | 2022-01-21 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Barna Nicole | See Remarks | A Award deriv | 2022-01-19 | 2022-01-21 | 29,000 | — | $0 | 29,000 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | A Award deriv | 2022-01-19 | 2022-01-21 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | A Award deriv | 2022-01-19 | 2022-01-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | A Award deriv | 2022-01-19 | 2022-01-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | A Award deriv | 2022-01-19 | 2022-01-21 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Howze Yalonda | See Remarks | A Award deriv | 2022-01-19 | 2022-01-21 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Howze Yalonda | See Remarks | A Award deriv | 2022-01-19 | 2022-01-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Brudnick Richard | See Remarks | A Award deriv | 2022-01-19 | 2022-01-21 | 8,400 | — | $0 | 8,400 | SEC↗ |
| Brudnick Richard | See Remarks | A Award deriv | 2022-01-19 | 2022-01-21 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Pandite Arundathy N. | Director | A Award deriv | 2021-08-16 | 2021-08-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise deriv | 2021-08-09 | 2021-09-28 | 1,300 | — | $0 | 48,666 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise | 2021-08-09 | 2021-09-28 | 1,300 | $3.29 | $4.3K | 1,300 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | S Sale | 2021-08-09 | 2021-09-28 | 549 | $21.79 | $12.0K | 0 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | S Sale | 2021-08-09 | 2021-09-28 | 751 | $21.31 | $16.0K | 549 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise deriv | 2021-08-06 | 2021-09-28 | 1,300 | — | $0 | 49,966 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | S Sale | 2021-08-06 | 2021-09-28 | 1,300 | $20.16 | $26.2K | 0 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | M Exercise | 2021-08-06 | 2021-09-28 | 1,300 | $3.29 | $4.3K | 1,300 | SEC↗ |
| MELAS KYRIAZI THEO | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Haddock Jason | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| COONEY CHARLES L | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Bernstein Karen | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Sathyanarayanan Sriram | Chief Scientific Officer | A Award deriv | 2021-06-09 | 2021-06-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | M Exercise deriv | 2021-06-08 | 2021-09-28 | 7,276 | — | $0 | 92,978 | SEC↗ |
| Sorensen Benny | See Remarks | M Exercise deriv | 2021-06-08 | 2021-09-28 | 8,533 | — | $0 | 87,411 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | M Exercise | 2021-06-08 | 2021-09-28 | 7,276 | $3.29 | $23.9K | 7,276 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | S Sale | 2021-06-08 | 2021-09-28 | 6,272 | $25.53 | $160.1K | 1,004 | SEC↗ |
| Konstantinov Konstantin | Chief Technology Officer | S Sale | 2021-06-08 | 2021-09-28 | 1,004 | $26.04 | $26.1K | 0 | SEC↗ |
| Sorensen Benny | See Remarks | M Exercise | 2021-06-08 | 2021-09-28 | 8,533 | $3.29 | $28.1K | 8,533 | SEC↗ |
| Sorensen Benny | See Remarks | S Sale | 2021-06-08 | 2021-09-28 | 6,893 | $25.57 | $176.3K | 1,640 | SEC↗ |
| Sorensen Benny | See Remarks | S Sale | 2021-06-08 | 2021-09-28 | 1,640 | $26.06 | $42.7K | 0 | SEC↗ |
| Eggimann Anne-Virginie | Director | A Award deriv | 2021-05-17 | 2021-05-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wheler Jennifer J. | Chief Medical Officer | A Award deriv | 2021-05-10 | 2021-05-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Morrison Briggs | Director | P Buy | 2021-02-17 | 2021-02-17 | 4,761 | $21.00 | $100.0K | 4,761 | SEC↗ |
| See Remarks | A Award deriv | 2021-01-22 | 2021-01-26 | 31,000 | — | $0 | 31,000 | SEC↗ | |
| WILLIAMS DOUGLAS E | President & CEO | A Award deriv | 2021-01-22 | 2021-01-26 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Barna Nicole | See Remarks | A Award deriv | 2021-01-22 | 2021-01-26 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Brudnick Richard | See Remarks | A Award deriv | 2021-01-22 | 2021-01-26 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Konstantinov Konstantin | See Remarks | A Award deriv | 2021-01-22 | 2021-01-26 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Howze Yalonda | See Remarks | A Award deriv | 2021-01-22 | 2021-01-26 | 37,000 | — | $0 | 37,000 | SEC↗ |
| Bain Linda | Chief Financial Officer | A Award deriv | 2021-01-22 | 2021-01-26 | 58,000 | — | $0 | 58,000 | SEC↗ |
| Verma Ajay | See Remarks | A Award deriv | 2021-01-22 | 2021-01-26 | 29,000 | — | $0 | 29,000 | SEC↗ |
| Haddock Jason | Director | A Award deriv | 2020-11-13 | 2020-11-17 | 7,996 | — | $0 | 7,996 | SEC↗ |
| Howze Yalonda | See Remarks | A Award deriv | 2020-11-13 | 2020-11-17 | 41,576 | — | $0 | 41,576 | SEC↗ |
| GILLIS STEVEN | Director | C Conversion deriv | 2020-10-16 | 2020-10-20 | 3,000,000 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | Director | C Conversion deriv | 2020-10-16 | 2020-10-20 | 13,950,000 | — | $0 | 0 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | C Conversion deriv | 2020-10-16 | 2020-10-20 | 66,004 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 2,416,666 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 660,048 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 660,048 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 2,416,666 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 4,250,000 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 4,250,000 | — | $0 | 0 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 6,500,000 | — | $0 | 0 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 13,950,000 | — | $0 | 0 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 1,320,097 | — | $0 | 0 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-20 | 2,333,333 | — | $0 | 0 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-23 | 3,333,333 | — | $0 | 0 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-23 | 1,320,097 | — | $0 | 0 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-23 | 5,333,333 | — | $0 | 0 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-23 | 20,450,000 | — | $0 | 0 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion deriv | 2020-10-16 | 2020-10-23 | 1,320,097 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | Director | P Buy | 2020-10-16 | 2020-10-20 | 235,000 | $15.00 | $3.52M | 2,503,903 | SEC↗ |
| GILLIS STEVEN | Director | C Conversion | 2020-10-16 | 2020-10-20 | 1,784,572 | — | $0 | 1,848,535 | SEC↗ |
| GILLIS STEVEN | Director | C Conversion | 2020-10-16 | 2020-10-20 | 420,368 | — | $0 | 2,268,903 | SEC↗ |
| WILLIAMS DOUGLAS E | President & CEO | C Conversion | 2020-10-16 | 2020-10-20 | 9,585 | — | $0 | 9,585 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 543,686 | — | $0 | 543,686 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 543,686 | — | $0 | 543,686 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 338,630 | — | $0 | 882,316 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 338,630 | — | $0 | 882,316 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 95,861 | — | $0 | 978,177 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 95,861 | — | $0 | 978,177 | SEC↗ |
| Flagship Ventures Fund V Gener | 10% Owner | P Buy | 2020-10-16 | 2020-10-20 | 165,000 | $15.00 | $2.48M | 1,143,177 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 831,521 | — | $0 | 831,521 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 191,721 | — | $0 | 1,350,195 | SEC↗ |
| CRANDELL KEITH | 10% Owner | P Buy | 2020-10-16 | 2020-10-20 | 235,000 | $15.00 | $3.52M | 2,503,903 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 1,784,572 | — | $0 | 1,848,535 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 326,953 | — | $0 | 1,158,474 | SEC↗ |
| CRANDELL KEITH | 10% Owner | C Conversion | 2020-10-16 | 2020-10-20 | 420,368 | — | $0 | 2,268,903 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion | 2020-10-16 | 2020-10-23 | 191,721 | — | $0 | 4,512,895 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion | 2020-10-16 | 2020-10-23 | 2,616,093 | — | $0 | 4,512,895 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion | 2020-10-16 | 2020-10-23 | 467,076 | — | $0 | 4,512,895 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion | 2020-10-16 | 2020-10-23 | 747,321 | — | $0 | 4,512,895 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | C Conversion | 2020-10-16 | 2020-10-23 | 191,721 | — | $0 | 4,512,895 | SEC↗ |
| Alaska Permanent Fund Corp | 10% Owner | P Buy | 2020-10-16 | 2020-10-23 | 235,000 | $15.00 | $3.52M | 4,512,895 | SEC↗ |
| MELAS KYRIAZI THEO | Director | P Buy | 2020-10-13 | 2021-04-30 | 6,600 | $15.00 | $99.0K | 6,600 | SEC↗ |
| COONEY CHARLES L | Director | A Award deriv | 2020-10-13 | 2020-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MELAS KYRIAZI THEO | Director | A Award deriv | 2020-10-13 | 2020-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Morrison Briggs | Director | A Award deriv | 2020-10-13 | 2020-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LANDER ERIC S | Director | A Award deriv | 2020-10-13 | 2020-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Bernstein Karen | Director | A Award deriv | 2020-10-13 | 2020-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Haddock Jason | Director | A Award deriv | 2020-10-13 | 2020-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2020-10-13 | 2020-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Haddock Jason | Director | A Award deriv | 2020-08-26 | 2020-10-15 | 31,981 | — | $0 | 31,981 | SEC↗ |
| Howze Yalonda | See Remarks | A Award deriv | 2020-07-02 | 2020-11-17 | 166,304 | — | $0 | 166,304 | SEC↗ |